Zealand does not currently have a disclosed clinical-stage triple agonist, which means its IP position is ahead of its product position
For obesity medicines specifically, NICE has historically applied criteria around BMI thresholds (in kg/m), comorbidities, and specialist service settings
Compounded medications are prepared by licensed pharmacies and are not reviewed by the FDA for safety, effectiveness, or quality
CrCl 3 days have elapsed since last dose, reinitiate at 0.6 mg dose Generic / Price YES/$$$$ Storage Unpunctured pens Keep refrigerated Good until expiration date if refrigerated Do not freeze Punctured pens Keep at room temperature or refrigerate Good for 30 days Do not freeze Semaglutide Ozempic Ozempic Dosage forms Multi-dose pen 2 mg/1.5 ml pen - discontinued 2 mg/3 ml pen - delivers 4 doses of 0.25 mg and 2 doses of 0.5 mg OR 4 doses of 0.5 mg 4 mg/3 ml pen - delivers four 1 mg doses 8 mg/3 ml pen - delivers four 2 mg doses Dosing Type 2 diabetes Starting: 0.25 mg SQ once weekly for 4 weeks
Retatrutide is promising because of its triple-agonist mechanism and strong weight-loss data, but current public evidence is not enough to make a firm superiority claim specifically for muscle preservation compared with semaglutide or tirzepatide
Processing takes 2-4 weeks, and approved patients receive 90-day supplies at no cost
